3 Must-Buy Value Stocks Amid High Inflation

These three TSX value stocks are excellent buying opportunities despite the persistently high inflation in 2022.

| More on:
falling red arrow and lifting

Image source: Getty Images

The Bank of Canada has raised its benchmark rate five times already but many expect two more hikes before 2022 is over. Meanwhile, given the uncertain conditions, market analysts believe value should take precedence if you’re investing in stocks.

Right now, you can capitalize on the lower valuations of National Bank of Canada (TSX:NA), Jamieson Wellness (TSX:JWEL), and Tamarack Valley Energy (TSX:TVE). The three TSX stocks are buying opportunities amid high inflation.

Recession is not a base case

National Bank of Canada reported lower net income in Q2 fiscal 2022 versus Q3 fiscal 2023, although it was a meager 2% drop to $826 million. Management said all business segments delivered solid performances during the quarter but offset by higher provisions for credit losses (PCLs).

The CEO of the $30.8 billion bank, Laurent Ferreira, said the boost in PCL stems from the persistent slowdown in economic growth, but not necessarily a recession. He adds, “Although the probability of a recession has increased over the past few weeks, it is not our base case.”

Ferreira further said, “Our economics team is currently calling for a soft landing of the Canadian economy.” If you’re an income investor, you shouldn’t need to worry about the depressed stock price and the bank’s ability to sustain dividend payments. At $91.58 per share (-3.12% year-to-date), Canada’s fifth-largest bank pays an attractive 4.24% dividend. Notably, the payout ratio is a low 34.2%.

Strong revenue growth

Jamieson Wellness is trading at a discount year to date. At $36.76 per share, the consumer staples stock is down 7.2%. However, the modest 1.85% dividend yield should compensate while the stock prepares to recover. Market analysts covering the stock have a 12-month average price target of $35 (+23.6% return potential).

The $1.5 billion company offers a portfolio of natural health products that help improve the health and wellness of customers worldwide. Despite the volatile geopolitical and economic environment, management said Jamieson could deliver on its strategic priorities and commitments.

In the first half of 2022, revenue and net earnings increased 3% and 13%, respectively, versus the same period in 2021. The highlight in Q2 2022 was the 161% year-over-year increase in cash from operations to $13.3 million. For the full-year, management anticipates annual revenue growth between 5% and 9% in the base business. Newly acquired Nutrawise should also deliver revenue growth of approximately 16%. This revenue boost represents about 3.5% of Jamieson’s forecasted $550–$565 million in fiscal 2022 revenues.

Massive capital gains

Tamarack Valley pays a modest 3.02% dividend, but it could deliver massive capital gains this year. At only $3.98 per share, the trailing one-year price return is 61.6%. Based on market analysts’ forecasts, the potential price appreciation in 12 months is 95% ($7.77).

The $1.65 billion oil and gas exploration and production company will generate more free funds flow if the oil price level of US$100 per barrel sustains for the rest of the year. In Q2 2022, cash flow from operations increased 433% year over year to $214.7 million. Because of soaring cash flows, the energy stock increased its monthly cash dividends by 20%.

Higher returns

National Bank, Jamieson Wellness, and Tamarack Valley are undervalued stocks vis-a-vis their growth and earnings potentials. The share prices today are well below their real or intrinsic values. Your overall returns should be boosted higher from both stock dividends and capital appreciation.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

More on Dividend Stocks

grow dividends
Dividend Stocks

1 Cheap Stock to Turn a $20,000 TFSA Into $267,000

If you're looking to boost your TFSA, you need a cheap stock that you can hold for decades. And I…

Read more »

edit Person using calculator next to charts and graphs
Dividend Stocks

2 of the Best Monthly Passive-Income Stocks to Buy in Canada Right Now

Here are two of the best Canadian monthly passive income stocks you can consider buying right now to hold for…

Read more »

stock analysis
Dividend Stocks

3 TSX Stocks I Will “Never” Sell

Few companies offer a powerful enough combination of dividends and growth potential to deserve a permanent place in your portfolio.

Read more »

value for money
Dividend Stocks

2 Cheap TSX Stocks for TFSA and RRSP Investors to Buy Now

These stocks look attractive today to buy for a TFSA or RRSP portfolio.

Read more »

Increasing yield
Dividend Stocks

3 TSX Stocks With High Dividend Yields

These three high-yielding dividend stocks would be excellent additions to your portfolio in this volatile environment.

Read more »

Payday ringed on a calendar
Dividend Stocks

New Investors: 3 Top TSX Dividend Stocks That Pay Cash Monthly

Canadian investors looking for monthly dividends have plenty of options on the TSX. Here's three of my favourite stocks for…

Read more »

woman data analyze
Dividend Stocks

These U.S. Stocks Are No-Brainer Additions to Your Portfolio

Buy these two no-brainer U.S. stocks if you want to gain exposure to international stocks in your self-directed portfolio.

Read more »

Value for money
Dividend Stocks

1 Value Stock Every Canadian Investor Should Own

This value stock not only has a solid present, but a stable future at incredibly cheap and even oversold prices!

Read more »